Statistics for Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
Total visits
views | |
---|---|
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer | 147 |
Total visits per month
views | |
---|---|
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
File Visits
views | |
---|---|
nihms-1536864.pdf | 162 |
java.util.UUID:9369ab0e-38e0-445e-8cef-9713797a32fe | 76 |
java.util.UUID:3fc691ef-de2a-4dc8-9aeb-b93698e909b7 | 25 |
java.util.UUID:5424b38c-aa3a-41f6-a025-af1c3fd3ab3f | 5 |
Top country views
views | |
---|---|
United States | 112 |
China | 5 |
Germany | 3 |
Canada | 2 |
Sweden | 2 |
Ukraine | 2 |
Switzerland | 1 |
United Kingdom | 1 |
Malaysia | 1 |
Russia | 1 |
Top city views
views | |
---|---|
Wilmington | 54 |
Houston | 13 |
Fairfield | 6 |
Jacksonville | 5 |
Shenzhen | 5 |
Ann Arbor | 3 |
Cambridge | 3 |
Kiez | 3 |
Lake Mary | 3 |
San Francisco | 3 |
Indianapolis | 2 |
Kiev | 2 |
Toronto | 2 |
Cointrin | 1 |
Moscow | 1 |
Mountain View | 1 |
Seremban | 1 |
Stockholm | 1 |